CPT® Code 87590

Infectious agent detection by nucleic acid (DNA or RNA) for Neisseria gonorrhoeae is a critical diagnostic procedure used to identify the presence of this bacterium, which is responsible for gonorrhea, a prevalent sexually transmitted disease (STD). Neisseria gonorrhoeae can infect various anatomical sites, including the reproductive tract, mouth, throat, eyes, and anus, primarily through direct contact during sexual activity. The infection often remains asymptomatic in women, which can lead to severe complications such as irreversible reproductive tract damage and infertility. In contrast, men typically exhibit symptoms such as burning, itching, and urethral discharge, although they are less likely to experience long-term reproductive damage. The procedure utilizes nucleic acid testing methods, which may include rapid tests that can be conducted in a physician's office using specific test kits. A specimen is collected via a swab from the cervix, male urethra, mouth, throat, or eye, depending on the site of suspected infection. The methodology for detecting N. gonorrhoeae varies based on the test kit employed, with some kits utilizing a nucleic acid hybridization technique. This involves the use of a single-stranded chemiluminescent DNA probe that is complementary to the ribosomal RNA of the organism. The process includes lysing cells to release nucleic acids, followed by the formation of stable DNA:RNA hybrids, which are then detected using a luminometer. This procedure is essential for timely diagnosis and treatment of gonorrhea, thereby preventing potential complications associated with untreated infections.